Company Name: |
Xenoah Pharmaceutical Inc.
|
Tel: |
0512-6956-1983 |
Email: |
info@xenoah.com |
Products Intro: |
Product Name:S-Facinicline CAS:677305-02-1 Purity:>97% Package:1g;10g;100g;1kg;25kg
|
|
| S-Facinicline Basic information |
Product Name: | S-Facinicline | Synonyms: | S-Facinicline;Facinicline hydrochloride;RG3487 hydrochloride;RG3487;Inhibitor,nAChR,serotonin 3 receptor,Nicotinic acetylcholine receptors,Serotonin Receptor,5-HT Receptor,inhibit,recognition,5-hydroxytryptamine Receptor,Facinicline,Facinicline hydrochloride,receptor,RG-3487,memory,RG 3487,nicotinic;Facinicline hydrochloride, 10 mM in DMSO | CAS: | 677305-02-1 | MF: | C15H19ClN4O | MW: | 306.79056 | EINECS: | | Product Categories: | | Mol File: | 677305-02-1.mol |  |
| S-Facinicline Chemical Properties |
storage temp. | Store at -20°C | solubility | DMSO: 125 mg/mL (407.44 mM); Methanol: 25 mg/mL (81.49 mM) | form | Solid | color | White to off-white |
| S-Facinicline Usage And Synthesis |
Biological Activity | Facinicline hydrochloride (RG3487 hydrochloride) is an orally active partial agonist of the nicotinic α7 receptor with a Ki of 6 nM for human nAChR. It (RG3487 hydrochloride) improves cognition and sensorimotor gating in rodents. Facinicline hydrochloride has a Ki value of 1.2 nM for the 5-HT3 receptor (antagonist). | in vitro | Facinicline (RG3487) activates human α7 nAChRs with an EC 50 of 0.8 μM (oocytes) and 7.7 μM (QM7 cells). It (RG3487) exhibits antagonist properties at the serotonin 3 receptor (IC 50 2.8 nM (oocytes), 32.7 nM (N1E-115 cells)). < /p> | in vivo | Facinicline (RG3487) improves object recognition memory in rats after acute [minimally effective dose (MED) 1.0 mg/kg po] or repeated (10 day) administration at brain and plasma concentrations in the low-nanomolar range. RG3487 (0.1–10 mg/kg po) selectively enhances object recognition memory. Animal Model: | Male Sprague-Dawley rats. | Dosage: | 0.1-10 mg/kg (Pharmacokinetic Analysis ). | Administration: | Orally. | < td class="col1 fwb"> Result: The mean C max was typically observed between 0.5 and 4 h. | | target | 5-HT 3 Receptor 1.2 nM (Ki) | α7 < span> 6 nM (Ki) | |
| S-Facinicline Preparation Products And Raw materials |
|